DOAJ Open Access 2022

Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome

Vito Romano Davide Romano Paolo Semeraro Eliana Forbice Antonio Iaria +4 lainnya

Abstrak

Purpose: To report increased corneal bioavailability of allogenic serum when used in combinations with Therapeutic Hyper-CL™ soft contact lens in a patient with severe Sjögren's syndrome-associated dry eye. Observations: A 57-year-old woman with a medical history of bilateral severe Sjögren's syndrome-associated dry eye and previous amniotic membrane patch for autoimmune corneal perforation in her left eye was referred for left eye recurrence of progressive melting and pending perforation. After manual corneal trephination, full thickness transplant and sutured amniotic membrane patch, a Therapeutic Hyper-CL™ soft contact lens (EyeYon Medical, Ness Tziona, Israel) was fit. The patient was commenced in the left eye with topical corticosteroid, antibiotic, and allogenic serum eye drops. In the right eye the patient had silicone hydrogel bandage contact lens and was under same treatment of the left eye for previous endothelial keratoplasty. In order to evaluate the efficacy and increased corneal availability of drugs provided by Therapeutic Hyper-CL™ compared with silicone hydrogel soft contact lens, anterior segment OCT was performed. Conclusions and importance: The anterior segment OCT showed a thicker meniscus of fluid and possibly subsequent increase of trophic factors bioavailability in left eye compared with right eye. Therefore, in case of severe and refractory dry-eye disease the combination of Therapeutic Hyper-CL™ and serum eye drops may be representing a valid therapeutic approach.

Topik & Kata Kunci

Penulis (9)

V

Vito Romano

D

Davide Romano

P

Paolo Semeraro

E

Eliana Forbice

A

Antonio Iaria

T

Teodoro Pizzolante

M

Micol Frassi

F

Franco Franceschini

F

Francesco Semeraro

Format Sitasi

Romano, V., Romano, D., Semeraro, P., Forbice, E., Iaria, A., Pizzolante, T. et al. (2022). Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome. https://doi.org/10.1016/j.ajoc.2022.101685

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1016/j.ajoc.2022.101685
Informasi Jurnal
Tahun Terbit
2022
Sumber Database
DOAJ
DOI
10.1016/j.ajoc.2022.101685
Akses
Open Access ✓